Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors
Immune checkpoint inhibitors have revolutionized the treatment paradigm of several cancers. However, not all patients respond to treatment. Tumor cells reprogram metabolic pathways to facilitate growth and proliferation. This shift in metabolic pathways creates fierce competition with immune cells f...
Main Authors: | Zainab Fatima, Abdulrahman Abonofal, Bettzy Stephen |
---|---|
Format: | Article |
Language: | English |
Published: |
Innovative Healthcare Institute
2023-05-01
|
Series: | Journal of Immunotherapy and Precision Oncology |
Subjects: | |
Online Access: | https://jipo.org/doi/pdf/10.36401/JIPO-22-27 |
Similar Items
-
Targeting T-cell metabolism to boost immune checkpoint inhibitor therapy
by: Haohao Li, et al.
Published: (2022-12-01) -
Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance
by: Chao-Yuan Weng, et al.
Published: (2021-01-01) -
Interleukin-33: Metabolic checkpoints, metabolic processes, and epigenetic regulation in immune cells
by: Jian Lin, et al.
Published: (2022-08-01) -
Role of mitochondrial metabolism in immune checkpoint inhibitors-related myocarditis
by: Xin Zhang, et al.
Published: (2023-01-01) -
The CD73 immune checkpoint promotes tumor cell metabolic fitness
by: David Allard, et al.
Published: (2023-06-01)